Sign In
Buy ABBV
$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
Roche's (RHHBY) Lunsumio Gets FDA Nod for Follicular Lymphoma
03:05pm, Friday, 23'rd Dec 2022 Zacks Investment Research
Following the FDA's approval, Roche (RHHBY) Lunsumio is the first CD20xCD3 T-cell engaging bispecific antibody approved to treat follicular lymphoma.
If You Invested $25,000 in AbbVie In 2020, This Is How Much You Would Have Today
02:16pm, Friday, 23'rd Dec 2022 The Motley Fool
In May 2020, the company closed on its acquisition of Botox maker Allergan.
MGV: Mega Cap Value ETF, Wrap It Up And Put A Bow On Top
05:23am, Friday, 23'rd Dec 2022 Seeking Alpha
The Vanguard Mega Cap Value ETF has outperformed the S&P 500 by ~16% over the past year. Read why I feel MGV ETF is very attractive.
Here's Why the Bear Market Could End in 2023
03:37pm, Wednesday, 21'st Dec 2022 The Motley Fool
Now could be the opportune time to load up on some quality growth stocks.
This Unstoppable Growth Stock Is Nearing a Once-In-a-Decade Buying Opportunity
02:53pm, Wednesday, 21'st Dec 2022 The Motley Fool
The risk of a stalled top line in 2023 means the potential for reward for those who can see beyond it.
2 Mammoth Stocks With Dividends to Buy Before 2022 Ends
01:05pm, Wednesday, 21'st Dec 2022 The Motley Fool
Blue chip healthcare stocks Johnson & Johnson and Cigna are always in season.
This Unstoppable Growth Stock Is Nearing a Once-In-a-Decade Buying Opportunity
09:53am, Wednesday, 21'st Dec 2022
The risk of a stalled top line in 2023 means the potential for reward for those who can see beyond it.
Bert's November Dividend Income Summary
10:09pm, Tuesday, 20'th Dec 2022
We save a high percentage of our income each month, to help fuel our dividend stock portfolio. We received $855.31 in November dividend income. This was an 11.93% increase compared to November 2021.
2 Exceptional Dividend Growth Stocks to Buy Now
05:47am, Tuesday, 20'th Dec 2022
These companies have histories of rapid payout increases and the means to continue them.
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
10:32am, Monday, 19'th Dec 2022
Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
AbbVie (ABBV) Vraylar Gets FDA Nod for Major Depressive Disorder
09:02am, Monday, 19'th Dec 2022
FDA approves AbbVie's (ABBV) Vraylar (cariprazine) for its fourth indication - the adjunctive treatment of patients with MDD.
The 7 Hottest Biotech Stocks to Own in 2023 and Beyond
06:21pm, Sunday, 18'th Dec 2022
Some of the hottest biotech stocks are safe and recession-proof. After all, we can't stop people from aging – at least, not yet.
Time to Buy Eli Lilly (LLY) and AbbVie (ABBV) Stock for 2023?
09:49pm, Friday, 16'th Dec 2022
AbbVie's valuation, in particular, makes it a potentially strong candidate for 2023, while Eli Lilly's growth could support its stock next year.
JPMorgan's bullish call on biopharma
02:12pm, Friday, 16'th Dec 2022
The "Halftime Report" traders debate the biggest analyst calls of the day.
Why Pfizer Stock Is Riskier Than AbbVie
05:52am, Friday, 16'th Dec 2022
Pfizer has a lot more revenue at risk over the next several years than AbbVie does.
